Synopsis
Synopsis
0
CEP/COS
0
VMF
0
Listed Dossiers
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (r)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1h-indole
2. (r)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1h-indole Monohydrobromide
3. 3-(1-methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1h-indole Hydrobromide
4. Eletriptan
5. Relpax
6. Uk 166,044
7. Uk 166044
8. Uk-116,044-04
9. Uk-116044-04
10. Uk-166,044
11. Uk-166044
1. 177834-92-3
2. Eletriptan Hbr
3. Relpax
4. Eletriptan Hydrobromide [usan]
5. Eletriptan (hydrobromide)
6. (r)-3-((1-methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1h-indole Hydrobromide
7. Eletriptan Monohydrobromide
8. Uk 116044-04
9. Chebi:61176
10. M41w832ta3
11. Uk-116,044-04
12. (r)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1h-indole Monohydrobromide
13. 5-[2-(benzenesulfonyl)ethyl]-3-[[(2r)-1-methylpyrrolidin-2-yl]methyl]-1h-indole;hydrobromide
14. Nsc-759258
15. 3-(((r)-1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)indole, Monohydrobromide
16. 5-[2-(phenylsulfonyl)ethyl]-3-[(2r)-pyrrolidin-2-ylmethyl]-1h-indole Hydrobromide
17. C22h26n2o2s.hbr
18. Unii-m41w832ta3
19. Relpax (tn)
20. Schembl317370
21. Chembl1201003
22. Dtxsid001016113
23. Hy-a0010
24. Eletriptan Hydrobromide (jan/usan)
25. Eletriptan Hydrobromide [mi]
26. Tox21_500408
27. Eletriptan Hydrobromide [jan]
28. Mfcd08141806
29. S3180
30. Akos024262728
31. Ac-3398
32. Bcp9000640
33. Ccg-221712
34. Cs-0379
35. Eletriptan Hydrobromide [mart.]
36. Nsc 759258
37. 3-[[(2r)-1-methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-1h-indole Hydrobromide
38. Eletriptan Hydrobromide [usp-rs]
39. Eletriptan Hydrobromide [who-dd]
40. Ncgc00261093-01
41. Bs-42146
42. Eletriptan Hydrobromide, >=98% (hplc)
43. Eletriptan Hydrobromide [orange Book]
44. Sw220149-1
45. D01973
46. J-011323
47. J-520433
48. Q27130865
49. 3-(n-methyl-2(r)-pyrrolidinyl Methyl)-5-[2-(phenyl Sulfonyl)ethyl]-1h-indole Hydrobromide
50. 3-(n-methyl-2(r)-pyrrolidinylmethyl)-5-(2-phenylsulphonylethly)-1h-indole Hydrobromide
51. 3-(n-methyl-2(r)-pyrrolidinylmethyl)-5-(2-phenylsulphonylethyl)-1h-indole Hydrobromide
52. 3-(n-methyl-2(r)-pyrrolidinylmethyl)-5-[2-(phenyl Sulfonyl)ethyl]-1h-indole Hydrobromide
53. 3-{[1-methylpyrrolidin-2(r)-yl]methyl}-5-(2-phenylsulphonylethyl)-1h-indole Hydrobromide
54. (r)-3-[(1-methyl-2-pyrrolidinyl) Methyl]-5-[2-(phenylsulfonyl) Ethyl]-1h-indole Monohydrobromide
55. 1h-indole, 3-(((2r)-1-methyl-2-pyrrolidinyl))methyl)-5-(2-(phenylsulfonyl)ethyl)-, Monohydrobromide
56. 1h-indole, 3-[[(2r)-1-methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-, Hydrobromide (1:1)
57. 3-[[(2r)-1-methyl-2-pyrrolidinyl]me Thyl]-5-[2-(phenylsulfonyl)ethyl]-1h-indole Hydrobromide
58. 5-[2-(benzenesulfonyl)ethyl]-3-[[(2r)-1-methylpyrrolidin-2-yl]methyl]-1h-indol-1-ium;bromide
Molecular Weight | 463.4 g/mol |
---|---|
Molecular Formula | C22H27BrN2O2S |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 6 |
Exact Mass | 462.09766 g/mol |
Monoisotopic Mass | 462.09766 g/mol |
Topological Polar Surface Area | 61.6 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 582 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Eletriptan hydrobromide |
Drug Label | RELPAX (eletriptan) Tablets contain eletriptan hydrobromide, which is a selective 5-hydroxytryptamine 1B/1D (5-HT1B/1D) receptor agonist. Eletriptan is chemically designated as (R)-3-[(1-Methyl-2-pyrrolidinyl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-... |
Active Ingredient | Eletriptan hydrobromide |
Dosage Form | Tablet |
Route | oral |
Strength | eq 40mg base; eq 20mg base; 40mg; 20mg |
Market Status | Tentative Approval |
Company | Apotex; Teva Pharms Usa |
2 of 2 | |
---|---|
Drug Name | Eletriptan hydrobromide |
Drug Label | RELPAX (eletriptan) Tablets contain eletriptan hydrobromide, which is a selective 5-hydroxytryptamine 1B/1D (5-HT1B/1D) receptor agonist. Eletriptan is chemically designated as (R)-3-[(1-Methyl-2-pyrrolidinyl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-... |
Active Ingredient | Eletriptan hydrobromide |
Dosage Form | Tablet |
Route | oral |
Strength | eq 40mg base; eq 20mg base; 40mg; 20mg |
Market Status | Tentative Approval |
Company | Apotex; Teva Pharms Usa |
Serotonin Receptor Agonists
Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)
Registration Number : 304MF10075
Registrant's Address : Area Industrial del Llobregat, C/Argent 1,08755 Castellbisbal Barcelona SPAIN
Initial Date of Registration : 2022-05-18
Latest Date of Registration :
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22912
Submission : 2009-06-29
Status : Active
Type : II
Date of Issue : 2025-04-24
Valid Till : 2028-05-25
Written Confirmation Number : WC-0002
Address of the Firm :
NDC Package Code : 15894-0031
Start Marketing Date : 2016-05-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : CA |
Registration Number : 229MF10147
Registrant's Address : Area Industrial del Llobregat, C/Argent 1,08755 Castellbisbal Barcelona SPAIN
Initial Date of Registration : 2017-07-31
Latest Date of Registration :
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-02-10
Pay. Date : 2015-09-25
DMF Number : 29616
Submission : 2015-09-24
Status : Active
Type : II
NDC Package Code : 63126-904
Start Marketing Date : 2015-09-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-04-20
Pay. Date : 2012-11-07
DMF Number : 24504
Submission : 2010-12-28
Status : Active
Type : II
Registration Number : 229MF10075
Registrant's Address : Plot No. 564/A/22, Road No. 92, Jubilee Hills, Hyderabad-500096, Telangana, India
Initial Date of Registration : 2017-04-07
Latest Date of Registration :
Date of Issue : 2022-07-06
Valid Till : 2025-08-04
Written Confirmation Number : WC-0118
Address of the Firm :
NDC Package Code : 65015-719
Start Marketing Date : 2015-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25076
Submission : 2011-06-27
Status : Active
Type : II
NDC Package Code : 65015-790
Start Marketing Date : 2015-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-07-12
Pay. Date : 2012-12-14
DMF Number : 26099
Submission : 2012-05-30
Status : Active
Type : II
Registration Number : 306MF10042
Registrant's Address : 7-2-A2, Hetero Corporate, Industrial Estates, Sanath Nagar, Hyderabad-500 018, Telangana, INDIA
Initial Date of Registration : 2024-03-13
Latest Date of Registration :
Date of Issue : 2022-09-30
Valid Till : 2025-08-08
Written Confirmation Number : WC-0066
Address of the Firm :
NDC Package Code : 65977-0059
Start Marketing Date : 2002-12-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30338
Submission : 2016-03-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27069
Submission : 2013-04-02
Status : Inactive
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22912
Submission : 2009-06-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23651
Submission : 2010-03-25
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-02-28
Pay. Date : 2017-01-19
DMF Number : 31336
Submission : 2017-01-21
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-12-18
Pay. Date : 2013-10-25
DMF Number : 24528
Submission : 2010-12-29
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-07-12
Pay. Date : 2012-12-14
DMF Number : 26099
Submission : 2012-05-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30338
Submission : 2016-03-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25076
Submission : 2011-06-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-20
Pay. Date : 2012-11-07
DMF Number : 24504
Submission : 2010-12-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27069
Submission : 2013-04-02
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-02-10
Pay. Date : 2015-09-25
DMF Number : 29616
Submission : 2015-09-24
Status : Active
Type : II
About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse the...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...
About the Company : Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company comme...
About the Company : BIOTECHNICA DWC LLC has carved a niche for itself in providing value added compliance, regulatory qualification, project management and GDP guidance services to pharma companies al...
About the Company : Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years...
About the Company : More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, ...
About the Company : In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territo...
About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and...
About the Company : In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life. Viatris (N...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
65
PharmaCompass offers a list of Eletriptan Hydrobromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Eletriptan Hydrobromide manufacturer or Eletriptan Hydrobromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Eletriptan Hydrobromide manufacturer or Eletriptan Hydrobromide supplier.
PharmaCompass also assists you with knowing the Eletriptan Hydrobromide API Price utilized in the formulation of products. Eletriptan Hydrobromide API Price is not always fixed or binding as the Eletriptan Hydrobromide Price is obtained through a variety of data sources. The Eletriptan Hydrobromide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Eletriptan HBr manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eletriptan HBr, including repackagers and relabelers. The FDA regulates Eletriptan HBr manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eletriptan HBr API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Eletriptan HBr manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Eletriptan HBr supplier is an individual or a company that provides Eletriptan HBr active pharmaceutical ingredient (API) or Eletriptan HBr finished formulations upon request. The Eletriptan HBr suppliers may include Eletriptan HBr API manufacturers, exporters, distributors and traders.
click here to find a list of Eletriptan HBr suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Eletriptan HBr DMF (Drug Master File) is a document detailing the whole manufacturing process of Eletriptan HBr active pharmaceutical ingredient (API) in detail. Different forms of Eletriptan HBr DMFs exist exist since differing nations have different regulations, such as Eletriptan HBr USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Eletriptan HBr DMF submitted to regulatory agencies in the US is known as a USDMF. Eletriptan HBr USDMF includes data on Eletriptan HBr's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Eletriptan HBr USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Eletriptan HBr suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Eletriptan HBr Drug Master File in Japan (Eletriptan HBr JDMF) empowers Eletriptan HBr API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Eletriptan HBr JDMF during the approval evaluation for pharmaceutical products. At the time of Eletriptan HBr JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Eletriptan HBr suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Eletriptan HBr Drug Master File in Korea (Eletriptan HBr KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Eletriptan HBr. The MFDS reviews the Eletriptan HBr KDMF as part of the drug registration process and uses the information provided in the Eletriptan HBr KDMF to evaluate the safety and efficacy of the drug.
After submitting a Eletriptan HBr KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Eletriptan HBr API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Eletriptan HBr suppliers with KDMF on PharmaCompass.
A Eletriptan HBr written confirmation (Eletriptan HBr WC) is an official document issued by a regulatory agency to a Eletriptan HBr manufacturer, verifying that the manufacturing facility of a Eletriptan HBr active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Eletriptan HBr APIs or Eletriptan HBr finished pharmaceutical products to another nation, regulatory agencies frequently require a Eletriptan HBr WC (written confirmation) as part of the regulatory process.
click here to find a list of Eletriptan HBr suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Eletriptan HBr as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Eletriptan HBr API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Eletriptan HBr as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Eletriptan HBr and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Eletriptan HBr NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Eletriptan HBr suppliers with NDC on PharmaCompass.
Eletriptan HBr Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Eletriptan HBr GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Eletriptan HBr GMP manufacturer or Eletriptan HBr GMP API supplier for your needs.
A Eletriptan HBr CoA (Certificate of Analysis) is a formal document that attests to Eletriptan HBr's compliance with Eletriptan HBr specifications and serves as a tool for batch-level quality control.
Eletriptan HBr CoA mostly includes findings from lab analyses of a specific batch. For each Eletriptan HBr CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Eletriptan HBr may be tested according to a variety of international standards, such as European Pharmacopoeia (Eletriptan HBr EP), Eletriptan HBr JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Eletriptan HBr USP).